Anti-immunoglobulin E therapy on chronic prurigo and cholinergic urticaria
Not Applicable
- Conditions
- Chronic prurigo and cholinergic urticaria
- Registration Number
- JPRN-jRCTs031180092
- Lead Sponsor
- Yokozeki Hiroo
- Brief Summary
This study showed that omalizumab might be effective and safe for the treatment of skin diseases which resemble to chronic spontaneous urticaria such as chronic prurigo and cholinergic urticaria.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
patients who are resistant to the treatments such as topical administration of steroid and orally administration of anti-histamine drugs
patients at age 20 or over
out patients
Exclusion Criteria
patients orally administrated immune suppressants or high-dose steroid within three months.
patients suffering from severe visceral diseases, autoimmune diseases, blood dosorders, and mental disorders
patients who is pregnant or breast-feed
patients judged inadequate to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method skin symptom
- Secondary Outcome Measures
Name Time Method itch, QOL, Blood examination